[go: up one dir, main page]

AR018767A1 - Derivados de beta-carbolina hipnoticos, proceso para su preparacion y medicamentos - Google Patents

Derivados de beta-carbolina hipnoticos, proceso para su preparacion y medicamentos

Info

Publication number
AR018767A1
AR018767A1 ARP990101166A ARP990101166A AR018767A1 AR 018767 A1 AR018767 A1 AR 018767A1 AR P990101166 A ARP990101166 A AR P990101166A AR P990101166 A ARP990101166 A AR P990101166A AR 018767 A1 AR018767 A1 AR 018767A1
Authority
AR
Argentina
Prior art keywords
optionally substituted
groups
cycloalkyl
hydrogen atom
beta
Prior art date
Application number
ARP990101166A
Other languages
English (en)
Original Assignee
Cemaf
Lab Besins Iscovesco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/042,990 external-priority patent/US6048868A/en
Application filed by Cemaf, Lab Besins Iscovesco filed Critical Cemaf
Publication of AR018767A1 publication Critical patent/AR018767A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Derivados de beta-carbolina de la formula general (I) (I y I), en las X representa un radical divalente de la formula (II); R1, R2, R3 y R4representan, independientemente entre sí, un átomo de hidrogeno, un radical hidroxilo, un alquilo inferior, unalcoxilo inferior, un ariloxilo, unradical halo o nitro o una cadena alifática no saturada, alquilcarbonilo inferior, alquilcarboniloxilo inferior, carboxilo; pudiendo estos gruposestar opcionalmente sustituidos. R5 representa un átomo de hidrogeno,un alquilo inferior, cicloalquilo, arilo, aralquilo inferior, alcoxilo inferior,alquilcarbonilo inferior, haloalquilcarbonilo inferior, alquiloxicarbonilo inferior, amino; pudiendo estos grupos estar opcionalmente sustituidos.R6, R7, R9, R10, R12,R1 3, R14 y R15 representan, independientemente entre sí, un átomo de hidrogeno, un radical alquilo inferior, un cicloalquiloinferior, haloalquilo inferior, perhaloalquilo inferior, arilo, aralquilo, alcoxilo inferior, cicloalcoxilo inferior, mono opol ihaloalcoxilo,ariloxilo, aralquiloxilo, hidroxialquilo, alquiloxialquilo, alquiltio inferior, cicloalquiltio inferior; pudiendo estos grupos estar opcionalmentesustituidos. R8 representa un alquilo inferior, un cicloalquilo inferior,hidroxialquilo, alquiloxialquilo, haloalquilo inferior, perhaloalquilo inferior;pudiendo estos grupos estar opcionalmente sustituidos. R11 representa un átomo de oxígeno o un átomo de azufre, opcionalmente sustituidos, un procesopara su preparaciony medicamentos.
ARP990101166A 1998-03-17 1999-03-17 Derivados de beta-carbolina hipnoticos, proceso para su preparacion y medicamentos AR018767A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/042,990 US6048868A (en) 1994-09-14 1998-03-17 Melatonin-antagonist β-carboline derivatives and analogues thereof containing naphthalenic structure, process for their preparation and their use as medicinal products

Publications (1)

Publication Number Publication Date
AR018767A1 true AR018767A1 (es) 2001-12-12

Family

ID=21924862

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101166A AR018767A1 (es) 1998-03-17 1999-03-17 Derivados de beta-carbolina hipnoticos, proceso para su preparacion y medicamentos

Country Status (24)

Country Link
EP (1) EP1064284B1 (es)
JP (1) JP4333036B2 (es)
CN (1) CN1115342C (es)
AR (1) AR018767A1 (es)
AT (1) ATE215087T1 (es)
AU (1) AU752364B2 (es)
BG (1) BG63973B1 (es)
BR (1) BR9908833A (es)
CA (1) CA2324270A1 (es)
DE (1) DE69901098T2 (es)
DK (1) DK1064284T3 (es)
ES (1) ES2174632T3 (es)
HU (1) HUP0101234A3 (es)
IL (1) IL138442A (es)
IS (1) IS2199B (es)
NO (1) NO317296B1 (es)
NZ (1) NZ506913A (es)
PL (1) PL193450B1 (es)
PT (1) PT1064284E (es)
RU (1) RU2210571C2 (es)
SK (1) SK284387B6 (es)
TR (1) TR200003596T2 (es)
UA (1) UA71911C2 (es)
WO (1) WO1999047521A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824829B1 (fr) * 2001-05-16 2005-06-03 Macef Nouveaux derives de dihydroimidazo [5,1-a]-beta-carboline, leur procede de preparation et leur application a titre de medicament
FR2904973A1 (fr) * 2006-08-18 2008-02-22 Fourtillan Snc Derives de 1-methylidene-pyrido[3,4-b]indole et leur utilisation en therapeutique.
FR2916200A1 (fr) * 2007-05-18 2008-11-21 Fourtillan Snc Nouveaux derives des 1,2,3,4,6,7,12,12a-octahydro pyrazino[1',2':1,6]pyrido[3,4-b]indoles, leur preparation et leur utilisation en therapeutique
NZ586120A (en) 2008-01-11 2012-07-27 Albany Molecular Res Inc (1-azinone) -substituted pyridoindoles as mch antagonists
WO2011003012A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003007A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
EP2448585B1 (en) 2009-07-01 2014-01-01 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
WO2012088124A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
US8697700B2 (en) 2010-12-21 2014-04-15 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
FI130627B (en) * 2021-03-31 2023-12-18 Equinorm Ltd Novel heterocyclic compounds and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283343A (en) * 1987-08-17 1994-02-01 Whitby Research, Inc. 2-aryl substituted N-acetyltryptamines and process of preparing such
FR2724384B1 (fr) * 1994-09-14 1999-04-16 Cemaf Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament

Also Published As

Publication number Publication date
HUP0101234A3 (en) 2002-12-28
JP4333036B2 (ja) 2009-09-16
EP1064284A1 (en) 2001-01-03
DE69901098D1 (de) 2002-05-02
DK1064284T3 (da) 2002-07-22
IL138442A (en) 2006-12-10
AU3270799A (en) 1999-10-11
PL342929A1 (en) 2001-07-16
DE69901098T2 (de) 2002-11-21
CN1299361A (zh) 2001-06-13
ATE215087T1 (de) 2002-04-15
AU752364B2 (en) 2002-09-19
NZ506913A (en) 2003-07-25
NO20004638L (no) 2000-11-16
EP1064284B1 (en) 2002-03-27
TR200003596T2 (tr) 2001-04-20
JP2002506867A (ja) 2002-03-05
NO317296B1 (no) 2004-10-04
UA71911C2 (en) 2005-01-17
BR9908833A (pt) 2000-11-21
BG63973B1 (bg) 2003-08-29
PT1064284E (pt) 2002-09-30
ES2174632T3 (es) 2002-11-01
CN1115342C (zh) 2003-07-23
IS2199B (is) 2007-02-15
PL193450B1 (pl) 2007-02-28
HUP0101234A2 (hu) 2001-12-28
IL138442A0 (en) 2001-10-31
RU2210571C2 (ru) 2003-08-20
SK284387B6 (sk) 2005-02-04
BG104768A (en) 2001-05-31
CA2324270A1 (en) 1999-09-23
NO20004638D0 (no) 2000-09-15
WO1999047521A1 (en) 1999-09-23
IS5627A (is) 2000-09-12
SK13852000A3 (sk) 2001-09-11

Similar Documents

Publication Publication Date Title
AR018767A1 (es) Derivados de beta-carbolina hipnoticos, proceso para su preparacion y medicamentos
DK0952151T3 (da) Mellemprodukter til anvendelse ved fremstilling af nye pyridoncarboxylsyrederivater eller deres salte
GR3030515T3 (en) Aroyl-piperidine derivatives
ATE72436T1 (de) 2-(methyl(4-piperidinyl)>-1,2,3,4-tetrahydro-9h pyrido(3,4-b>indolderivate, ihre herstellung und therapeutische verwendung.
ES8601905A1 (es) Procedimiento para la obtencion de 5-amino-1-fenil-pirazolessustituidos
ES2120100T3 (es) O-bencil-oximeteres y agentes protectores de las plantas que contienen estos compuestos.
PT795025E (pt) Preparacao enantiosselectiva de sulfoxidos farmaceuticamente aceitaveis por bio-reducao
AU658609B2 (en) New indole derivatives, preparation processes and medicinal products containing them
CO4950539A1 (es) Derivados de aminoacidos inhibidores de las metaloproteasas de la matriz extracelular y de la liberacion del tnf .
FI964772A0 (fi) (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa
NZ332990A (en) oral pharmaceutical composition containing a H+, K+-atpase inhibitor having a extended blood plasma profile
PE20001565A1 (es) Inhibidores de metaloproteasa conteniendo alquenil y alquinil
DE69317439D1 (de) Azoxycyanbenzol-Derivate
FR2719043B1 (fr) Nouveaux composés bicycliques-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
DK0691951T3 (da) Fremgangsmåde til fremstilling af beta-phenylisoserinderivater
NO961456L (no) Nye tricykliske amider, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger som inneholder dem
DK0591046T3 (da) Chromenderivater med en trienkæde til anvendelse ved behandling af osteoporose og inflammatoriske sygdomme
NO940019D0 (no) Fremgangsmaate for fremstilling av svovelholdige imidazolderivater
DE3864193D1 (de) Substituierte 5-amino-pyrazole und diese enthaltende fungizide.
GB9116056D0 (en) Compounds
DK0590415T3 (da) 1,2,4-Oxadiazolderivater til bekæmpelse af endoparasitter
DK0830342T3 (da) Azolyloxybenzyl-alkoxyacrylsyreestre, fremgangsmåde til fremstilling heraf og anvendelsen heraf
FI834453A0 (fi) Nya pyrrolidin-derivat, deras frarmstaellning och dessa innehaollande laekemedel
EP0192951B1 (en) 5-sulfonamido-1-aryl pyrazoles

Legal Events

Date Code Title Description
FG Grant, registration